Literature DB >> 31750764

Longitudinal Analysis of Bidirectional Relationships between Nocturia and Depressive Symptoms: The Nagahama Study.

Satoshi Funada1,2, Yasuharu Tabara3, Hiromitsu Negoro4, Shusuke Akamatsu1, Takayuki Yoshino1, Koji Yoshimura5, Norio Watanabe2, Toshiaki A Furukawa2, Fumihiko Matsuda3, Osamu Ogawa1.   

Abstract

PURPOSE: Although the association between nocturia and depressive symptoms has been demonstrated, the causal direction remains unclear. We investigated the directional association between nocturia and depressive symptoms using longitudinal data from the general population.
MATERIALS AND METHODS: This longitudinal analysis was conducted as part of the Nagahama Cohort Project, a population based cohort study, with baseline and 5-year followup investigations. Nocturnal voiding frequency and mental health were measured with self-report questionnaires, the International Prostate Symptom Score and the 5-item Mental Health Inventory. Logistic regression analyses and a cross-lagged panel analysis were performed to analyze the bidirectional association between nocturia and depressive symptoms.
RESULTS: With 9,764 participants at baseline, data from 8,285 were used in this analysis. Median age at baseline was 57.3 years and the proportion of men was 32.0%. New onset depressive symptoms and nocturia were observed among 369 and 793 participants, respectively. In adjusted logistic regression analyses we observed a clear dose-relationship between baseline nocturnal voiding frequency and new onset depressive symptoms (p for trend <0.001) and a weak association between baseline 5-item Mental Health Inventory and new onset nocturia (p for trend=0.0087). In a cross-lagged panel analysis the path coefficient from nocturnal voiding frequency to 5-item Mental Health Inventory (β=-0.06, p <0.001) was stronger than that from 5-item Mental Health Inventory to nocturnal voiding frequency (β=-0.02, p=0.047).
CONCLUSIONS: This longitudinal study demonstrated a bidirectional association between nocturia and depressive symptoms. The cross-lagged path coefficient suggested that nocturia could more likely be a cause than a result of depressive symptoms.

Entities:  

Keywords:  depression; longitudinal studies; mental health; nocturia

Year:  2019        PMID: 31750764     DOI: 10.1097/JU.0000000000000683

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  4 in total

1.  Impact of Sleep Disturbance, Physical Function, Depression and Anxiety on Male Lower Urinary Tract Symptoms: Results from the Symptoms of Lower Urinary Tract Dysfunction Research Network (LURN).

Authors:  Alexander P Glaser; Sarah Mansfield; Abigail R Smith; Brian T Helfand; H Henry Lai; Aruna Sarma; Claire C Yang; Michelle Taddeo; J Quentin Clemens; Anne P Cameron; Kathryn E Flynn; Victor Andreev; Matthew O Fraser; Bradley A Erickson; Ziya Kirkali; James W Griffith
Journal:  J Urol       Date:  2022-02-25       Impact factor: 7.600

2.  Jingui Shenqi pill for nocturia due to nocturnal polyuria: A protocol for systematic review and meta-analysis.

Authors:  Zhipeng Fan; Zhaodi Wang; Jiashuai Deng; Yong Jiang
Journal:  Medicine (Baltimore)       Date:  2020-12-18       Impact factor: 1.817

3.  Protocol for development and validation of a prediction model for 5-year risk of incident overactive bladder in the general population: the Nagahama study.

Authors:  Satoshi Funada; Yan Luo; Takashi Yoshioka; Kazuya Setoh; Yasuharu Tabara; Hiromitsu Negoro; Shusuke Akamatsu; Koji Yoshimura; Fumihiko Matsuda; Toshi A Furukawa; Orestis Efthimiou; Osamu Ogawa
Journal:  BMC Urol       Date:  2021-05-13       Impact factor: 2.264

4.  Development and validation of prediction model for incident overactive bladder: The Nagahama study.

Authors:  Satoshi Funada; Yan Luo; Takashi Yoshioka; Kazuya Setoh; Yasuharu Tabara; Hiromitsu Negoro; Koji Yoshimura; Fumihiko Matsuda; Orestis Efthimiou; Osamu Ogawa; Toshi A Furukawa; Takashi Kobayashi; Shusuke Akamatsu
Journal:  Int J Urol       Date:  2022-04-07       Impact factor: 2.896

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.